Evidence map›Paper›PMID 27511021›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

miR-155 Deletion in Mice Overcomes Neuron-Intrinsic and Neuron-Extrinsic Barriers to Spinal Cord Repair.

Andrew D Gaudet, Shweta Mandrekar-Colucci, Jodie C E Hall, David R Sweet, Philipp J Schmitt, Xinyang Xu, Zhen Guan, Xiaokui Mo, Mireia Guerau-de-Arellano, Phillip G Popovich

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Spinal cord injury regulates circular RNA expression in axons.Frontiers in molecular neuroscience · 2023
    Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Andrew D GaudetCenter for Brain and Spinal Cord Repair, Department of Neuroscience, Wexner Medical Center, andrew.gaudet@colorado.edu phillip.popovich@osumc.edu.ORCID 0000-0001-8828-1553
Shweta Mandrekar-ColucciCenter for Brain and Spinal Cord Repair, Department of Neuroscience, Wexner Medical Center.ORCID 0000-0002-4296-302X
Jodie C E HallCenter for Brain and Spinal Cord Repair, Department of Neuroscience, Wexner Medical Center.ORCID 0000-0002-4820-6070
David R SweetCenter for Brain and Spinal Cord Repair, Department of Neuroscience, Wexner Medical Center.ORCID 0000-0002-1982-2958
Philipp J SchmittCenter for Brain and Spinal Cord Repair, Department of Neuroscience, Wexner Medical Center.ORCID 0000-0002-8704-8714
Xinyang XuCenter for Brain and Spinal Cord Repair, Department of Neuroscience, Wexner Medical Center.ORCID 0000-0002-8958-2005
Zhen GuanCenter for Brain and Spinal Cord Repair, Department of Neuroscience, Wexner Medical Center.
Xiaokui MoCenter for Biostatistics, and.
Mireia Guerau-de-ArellanoDepartment of Neuroscience, Medical Laboratory Science, School of Health and Rehabilitation Sciences, College of Medicine, The Ohio State University, Columbus, Ohio 43210.ORCID 0000-0002-0600-4593
Phillip G PopovichCenter for Brain and Spinal Cord Repair, Department of Neuroscience, Wexner Medical Center, andrew.gaudet@colorado.edu phillip.popovich@osumc.edu.ORCID 0000-0003-1329-7395
The Ohio State University Wexner Medical Center · USSociety for Neuroscience · US

Funding

Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunityR01AI121405 · NIAID · OHIO STATE UNIVERSITY · PI GUERAU-DE-ARELLANO, MIREIA · 2016 to 2020
$2.2M
miRNA Regulation of Macrophages after Spinal Cord InjuryR21NS081413 · NINDS · OHIO STATE UNIVERSITY · PI GUERAU-DE-ARELLANO, MIREIA, POPOVICH, PHILLIP G · 2012 to 2013
$413k
Novel Epigenetic Modifier Inhibitor Drugs for T cell Modulation in Multiple SclerosisR21AI127354 · NIAID · OHIO STATE UNIVERSITY · PI GUERAU-DE-ARELLANO, MIREIA · 2017 to 2018
$404k
CIHRNIAID NIH HHS R01 AI121405NIAID NIH HHS R21 AI127354NINDS NIH HHS R21 NS081413
6 · The paper itself

Abstract

unlabelledAxon regeneration after spinal cord injury (SCI) fails due to neuron-intrinsic mechanisms and extracellular barriers including inflammation. microRNA (miR)-155-5p is a small, noncoding RNA that negatively regulates mRNA translation. In macrophages, miR-155-5p is induced by inflammatory stimuli and elicits a response that could be toxic after SCI. miR-155 may also independently alter expression of genes that regulate axon growth in neurons. Here, we hypothesized that miR-155 deletion would simultaneously improve axon growth and reduce neuroinflammation after SCI by acting on both neurons and macrophages. New data show that miR-155 deletion attenuates inflammatory signaling in macrophages, reduces macrophage-mediated neuron toxicity, and increases macrophage-elicited axon growth by ∼40% relative to control conditions. In addition, miR-155 deletion increases spontaneous axon growth from neurons; adult miR-155 KO dorsal root ganglion (DRG) neurons extend 44% longer neurites than WT neurons. In vivo, miR-155 deletion augments conditioning lesion-induced intraneuronal expression of SPRR1A, a regeneration-associated gene; ∼50% more injured KO DRG neurons expressed SPRR1A versus WT neurons. After dorsal column SCI, miR-155 KO mouse spinal cord has reduced neuroinflammation and increased peripheral conditioning-lesion-enhanced axon regeneration beyond the epicenter. Finally, in a model of spinal contusion injury, miR-155 deletion improves locomotor function at postinjury times corresponding with the arrival and maximal appearance of activated intraspinal macrophages. In miR-155 KO mice, improved locomotor function is associated with smaller contusion lesions and decreased accumulation of inflammatory macrophages. Collectively, these data indicate that miR-155 is a novel therapeutic target capable of simultaneously overcoming neuron-intrinsic and neuron-extrinsic barriers to repair after SCI. SIGNIFICANCE STATEMENT: Axon regeneration after spinal cord injury (SCI) fails due to neuron-intrinsic mechanisms and extracellular barriers, including inflammation. Here, new data show that deleting microRNA-155 (miR-155) affects both mechanisms and improves repair and functional recovery after SCI. Macrophages lacking miR-155 have altered inflammatory capacity, which enhances neuron survival and axon growth of cocultured neurons. In addition, independent of macrophages, adult miR-155 KO neurons show enhanced spontaneous axon growth. Using either spinal cord dorsal column crush or contusion injury models, miR-155 deletion improves indices of repair and recovery. Therefore, miR-155 has a dual role in regulating spinal cord repair and may be a novel therapeutic target for SCI and other CNS pathologies.

Indexed as

AnimalsAxonsCalcium-Binding ProteinsCells, CulturedGanglia, SpinalGene Expression RegulationGreen Fluorescent ProteinsLectins, C-TypeMannose-Binding LectinsMannose ReceptorMiceMice, Inbred C57BLMice, TransgenicMicrofilament ProteinsMicroRNAsNeuritesAif1 protein, mouseCalcium-Binding ProteinsGreen Fluorescent ProteinsLectins, C-TypeMannose-Binding LectinsMannose ReceptorMicrofilament ProteinsMicroRNAsMirn155 microRNA, mouseReceptors, Cell Surfaceaxon regenerationmicroRNAneuroinflammationneuroprotectionspinal cord injury

Identifiers

PMID27511021
PMCPMC4978808
OpenAlexW2491292286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.